Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.

[1]  M. Matsuda,et al.  Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. , 2005, American journal of physiology. Endocrinology and metabolism.

[2]  J. Seufert,et al.  Leptin Effects on Pancreatic β-Cell Gene Expression and Function , 2004 .

[3]  B. Spiegelman,et al.  Targeted Elimination of Peroxisome Proliferator-Activated Receptor γ in β Cells Leads to Abnormalities in Islet Mass without Compromising Glucose Homeostasis , 2003, Molecular and Cellular Biology.

[4]  A. Tsuchida,et al.  Antiobesity and antidiabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance , 2003, International Journal of Obesity.

[5]  Bei B. Zhang,et al.  Glucagon and regulation of glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[6]  Y. Nakatani,et al.  Brain-derived neurotrophic factor ameliorates hepatic insulin resistance in Zucker fatty rats. , 2003, Metabolism: clinical and experimental.

[7]  Tomoo Ikarashi,et al.  Brain‐derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism , 2003, Diabetes, obesity & metabolism.

[8]  M. Iwai,et al.  Glucagon attenuates the action of insulin on glucose output in the liver of the Goto-Kakizaki rat perfused in situ , 2001, Pflügers Archiv.

[9]  M. Kasuga,et al.  The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice , 2001, Diabetologia.

[10]  M. Stumvoll,et al.  Pathophysiology and pharmacological treatment of insulin resistance. , 2000, Endocrine reviews.

[11]  J. Auwerx,et al.  Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells , 2000, Diabetologia.

[12]  Y Itakura,et al.  Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. , 2000, Diabetes.

[13]  G. Yancopoulos,et al.  Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. , 1999, Diabetes.

[14]  C. Ricordi,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Leptin Suppression of Insulin Secretion and Gene Expression in Human Pancreatic Islets: Implications for the Development of Adipogenic Diabetes Me , 2022 .

[15]  C. Newgard,et al.  Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells , 1998 .

[16]  Y Itakura,et al.  Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. , 1997, Biochemical and biophysical research communications.

[17]  J. Auwerx,et al.  Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat , 1997, Diabetes.

[18]  D. Romsos,et al.  Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. , 1997, The Journal of clinical investigation.

[19]  V. Emilsson,et al.  Expression of the Functional Leptin Receptor mRNA in Pancreatic Islets and Direct Inhibitory Action of Leptin on Insulin Secretion , 1997, Diabetes.

[20]  D. Holtzman,et al.  Nerve growth factor and the neurotrophic factor hypothesis , 1996, Brain and Development.

[21]  H. Koizumi,et al.  Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. , 1996, The American journal of pathology.

[22]  Shokei Kim,et al.  Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. , 1995, Circulation.

[23]  R. Kahn.  Causes of insulin resistance , 1995, Nature.

[24]  Stanley J. Wiegand,et al.  Neurotrophic factors: from molecule to man , 1994, Trends in Neurosciences.

[25]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[26]  S. Korsching,et al.  The neurotrophic factor concept: a reexamination , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[28]  F. Murray,et al.  Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes. , 2004, American journal of physiology. Endocrinology and metabolism.

[29]  T. Nakagawa,et al.  Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. , 2000, Metabolism: clinical and experimental.

[30]  S. Genuth,et al.  Forum One: Current Recommendations about Intensification of Metabolic Control in Non-Insulin-dependent Diabetes Mellitus , 1996, Annals of Internal Medicine.

[31]  R. Henry.  Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus. , 1996, Annals of internal medicine.

[32]  Y. Barde,et al.  Physiology of the neurotrophins. , 1996, Annual review of neuroscience.

[33]  M. Barbacid.  Neurotrophic Factors and Their Receptors , 1995, Bio/Technology.

[34]  M. Skup.  BDNF and NT-3 widen the scope of neurotrophin activity: pharmacological implications. , 1994, Acta neurobiologiae experimentalis.

[35]  K. Jungermann,et al.  Relative contribution of glycogenolysis and gluconeogenesis to basal, glucagon- and nerve stimulation-dependent glucose output in the perfused liver from fed and fasted rats. , 1990, Biochemistry international.